New Insights into Inflammatory Bowel Disease
The incidence of chronic inflammatory and autoimmune diseases is steadily increasing. Inflammatory bowel disease (IBD) is one example of a chronic inflammatory disease, which primarily affects the intestine but may also affect extraintestinal organs. The exact pathogenesis of IBD is currently unknow...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
IntechOpen
2016
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_129355 | ||
005 | 20231201 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20231201s2016 xx |||||o ||| 0|eng d | ||
020 | |a 61540 | ||
020 | |a 9789535127550 | ||
020 | |a 9789535127543 | ||
020 | |a 9789535141679 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.5772/61540 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a MJJ |2 bicssc | |
100 | 1 | |a Huber, Samuel |4 edt | |
700 | 1 | |a Huber, Samuel |4 oth | |
245 | 1 | 0 | |a New Insights into Inflammatory Bowel Disease |
260 | |b IntechOpen |c 2016 | ||
300 | |a 1 electronic resource (264 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a The incidence of chronic inflammatory and autoimmune diseases is steadily increasing. Inflammatory bowel disease (IBD) is one example of a chronic inflammatory disease, which primarily affects the intestine but may also affect extraintestinal organs. The exact pathogenesis of IBD is currently unknown. However, it is clear that the pathogenesis is complex, involving barrier defects, changes in the intestinal microbiome, and chronic immune activation. This book aims to summarize basic aspects of these complex interactions between barrier function, microbiome, and the immune system. Of note, there is currently no cure for IBD. However, several therapies have evolved in the last years, which are overall able to-at least temporarily-suppress IBD. These therapies and the underlying mechanism are discussed. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/3.0/ |2 cc |4 https://creativecommons.org/licenses/by/3.0/ | ||
546 | |a English | ||
650 | 7 | |a Hepatology |2 bicssc | |
653 | |a cytokines, crohn's disease, ulcerative colitis, th17, epidemiology, pathogenesis | ||
856 | 4 | 0 | |a www.oapen.org |u https://mts.intechopen.com/storage/books/5204/authors_book/authors_book.pdf |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/129355 |7 0 |z DOAB: description of the publication |